Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 950 results for "cholesterol"

FOXNews.com

Express Scripts says costly new cholesterol drugs could wreak havoc

July 29 (Reuters) - Express Scripts Holding Co, the largest pharmacy benefit manager in the United States, on Wednesday said the cost of potent new cholesterol drugs called PCSK9 inhibitors could "wreak financial havoc" among its clients. ...
 CNBC4 days ago CORRECTED-BRIEF-Express Scripts says cost of PCSK9 cholesterol drugs could "wreak financial havoc"  Reuters4 days ago Terror: Getting rid of backward cholesterol of ideology  DangoteNews.com3 days ago Stock Update: Express Scripts Holding Company (NASDAQ:ESRX) Express Scripts says costly new cholesterol drugs could wreak havoc  Marketplace4 days ago
[x]  
Med India

Type 2 Diabetes (T2DM) Cholesterol and Statins.

Statins for people at low risk As part of the Open Data Campaign (1) An editorial Statins for people at low risk stated, In particular, how can it be right to recommend mass treatment of healthy people without independent review of the patient level ...
 British Medical Journal3 days ago Utility of Non-Traditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 ACC/AHA Cholesterol Guidelines [Original Articles]  Circulation: Cardiovascular Interventions3 days ago High Bar for Patients Seeking New Cholesterol Drugs  Austin American Statesman5 days ago Cholesterol-Lowering Drugs Can Reduce Stroke Risk in Seniors  Med India2 months ago
MedIndia

Sitting For Long Periods Linked To Increased Blood Sugar, Cholesterol Levels

Being healthier may be found in something as simple as standing more and sitting less at work, said a study Friday. Replacing sitting time with standing time appeared to improve sugar, fat and cholesterol levels in the blood, researchers wrote in ...
 MedIndia2 days ago Stand, Don't Sit, to Get Healthier, Scientists Say  Doctors Lounge2 days ago Get up, stand up: stand up for your waist!  NewsOnFeeds.com2 days ago 9 Ways Your Friends Are Actually Good For Your Health  Indiatimes12 hours ago
[x]  
Boston Globe

Federal Regulators OK First Of New, Costly Class Of Cholesterol-Lowering Drugs

 Kaiser Health News6 days ago US approves drug that can sharply lower cholesterol levels  Boston Globe1 week ago New drug sharply lowers cholesterol, but it's costly  Today Online1 week ago New Drug Lowers Levels of Triglyceride Blood Fats: Study  MedicineNet.com2 days ago

Studies show superiority of ACC/AHA guidelines for managing blood cholesterol

Two studies published this month in JAMA clarified and proved the cost-effectiveness of statins and the validity of controversial guidelines for managing blood cholesterol. Whether the results will lead to more people receiving treatment remains to ...
 Cardiovascular Business3 days ago Cholesterol and your heart  Deccan Herald1 week ago
Jutia Group

Lilly continues test of HDL cholesterol drug, on panel's advice

July 27 (Reuters) - Eli Lilly and Co on Monday said it would continue a large study of its high-profile experimental drug to raise "good" HDL cholesterol and lower "bad" LDL cholesterol, acting on the recommendation of a data monitoring ...
 Yahoo! Finance6 days ago Stock Update (NYSE:LLY): Lilly continues test of HDL cholesterol drug, on panel's advice  Market Pulse Navigator6 days ago
[x]  
Reuters

Battle coming for blockbuster cholesterol drugs

The injectable drugs, known as PCSK9 inhibitors, could cost an estimated USD 7,000 to USD 12,000 per year for each person using the drug.
 Money Control1 week ago Fight over hot new cholesterol drugs may be won in milligrams  Reuters2 months ago Insight: Fight over hot new cholesterol drugs may be won in milligrams  Reuters2 months ago

Sanofi and Regeneron Pharmaceuticals awarded US FDA approval for Praluent Injection for treating High LDL cholesterol in adult patients

Therapeutic solution company Sanofi (Paris:SAN.PA) and Regeneron Pharmaceuticals jointly disclosed the receipt of US Food and Drug Administration (FDA) approval for Praluent (alirocumab) Injection for treating High LDL cholesterol in adult patients.
 Bloomberg6 days ago
Sky News Australia

New cholesterol drug gets limited nod

US regulators have approved a new cholesterol drug called Praluent for people with certain genetic risk factors for heart disease. The injectable drug, made by Sanofi and Regeneron, is the first of its kind to gain approval on the US market, and ...
 Sky News Australia1 week ago US regulators give limited approval to cholesterol drug  Yahoo! News1 week ago U.S. Regulators Give Limited Approval to Cholesterol Drug  Naharnet1 week ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less